| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |